Mary Tagliaferri

Dr. Mary A. Tagliaferri, MD, is an Independent Director at Iambic Therapeutics, Inc. and a Chief Medical Officer at Nektar Therapeutics.
She is on the Board of Directors at ADARx Pharmaceuticals, Inc. and Iambic Therapeutics, Inc. Dr. Tagliaferri was previously employed as an Independent Director by Y-mAbs Therapeutics, Inc., an Independent Director by Rayzebio, Inc., an Independent Director by Enzo Biochem, Inc., a Chief Medical Officer by Kanglaite USA, Inc., a President, Secretary, Treasurer & Director by Bionovo, Inc., and a Secretary, Treasurer & Chief Regulatory Officer by Lighten Up Enterprises International, Inc. She also served on the board at Atossa Therapeutics, Inc. She received her undergraduate degree from Cornell University, a graduate degree from American College of Traditional Chinese Medicine and a doctorate degree from The University of California, San Francisco.